AI assistant
Sending…
BROWN FORMAN CORP — Director's Dealing 2015
May 19, 2015
30482_dirs_2015-05-19_499067f4-64f2-4f61-958c-29e4befef8e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BROWN FORMAN CORP (BF'B)
CIK: 0000014693
Period of Report: 2015-05-18
Reporting Person: Brown Christina Lee (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-18 | Class B Common | M | 5311.0000 | $33.6500 | Acquired | 5311.0000 | Direct |
| 2015-05-18 | Class B Common | F | 1881.0000 | $95.0500 | Disposed | 3430.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-18 | Stock Appreciation Right | $33.6500 | M | 5311.0000 | Disposed | 2015-07-24 | Class B Common (5311.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common | 253368.0000 | Direct |
| Class B Common | 62404.0000 | Indirect |
| Class B Common | 1980.0000 | Indirect |
| Class B Common | 253176.0000 | Indirect |
| Class A Common | 3330114.0000 | Indirect |
| Class B Common | 6703641.0000 | Indirect |
| Class A Common | 504775.0000 | Indirect |
| Class B Common | 126193.0000 | Indirect |
| Class A Common | 1277100.0000 | Indirect |
| Class B Common | 343600.0000 | Indirect |
| Class A Common | 67714.0000 | Indirect |
Footnotes
F1: Totals updated to reflect the transfer of 62,404 Class B shares to Blue Heron Holdings LLC.
F2: The closing price of BF-B ($95.05) on May 15, 2015 was used to calculate the withholding obligation.
F3: Name of account has been updated.
More from BROWN FORMAN CORP
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 9
Interim / Quarterly Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 13